SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-029775
Filing Date
2020-10-29
Accepted
2020-10-29 20:45:15
Documents
2
Period of Report
2020-10-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 10233
2 EX-24 DOCUMENT attachment1.htm EX-24 4307
  Complete submission text file 0000899243-20-029775.txt   15926
Mailing Address C/O IDENIX PHARMACUEUTICALS 60 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address
Corcoran Andrea (Reporting) CIK: 0001296996 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39661 | Film No.: 201274369

Mailing Address 125 SUMMER STREET 16TH FLOOR BOSTON MA 02110
Business Address 125 SUMMER STREET 16TH FLOOR BOSTON MA 02110 857-204-8109
Atea Pharmaceuticals, Inc. (Issuer) CIK: 0001593899 (see all company filings)

IRS No.: 460574869 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations